Boundless Bio, Inc.

US$2.46As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BOLDHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (49.03%)
Div yield —
ROE (67.86%)
Biotechnology
Beta (5Y) 0.46
PE TTM —
TSR TTM 75.71%
Mkt cap US$55.96M
ROIC (34.84%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.02
22.73%
(4.82%)
Hold 3|5|1|7|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
(0.36%)
(0.56%)
(1.63%)
(0.58%)
Revenue$M
3.472
3.413
3.597
3.667
5.79%
1.03%
9.54%
6.65%
Peers (US$55.96M)
Cap (US$)
PE
56.15M
—
Capital
TTM
5Y
10Y
Leveragex
1.094
0.123
0.118
EBIT/Intx
1.359
1.261
1.154
Own earn%
73.76
(57.97)
(66.55)
Sh yield%
53.72
25.27
21.07
Owners
Insiders/Inst%
14.69
85.48
Short interest%
1.43
SBC / revenue%
4.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
22–36
$1 testx
—
Incr. ROIC%
10